Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-EN Version v1-EN
Language English English
Date Updated 2023-07-06 2023-02-01
Drug Identification Number 02377209 02377209
Brand name NOVORAPID NOVORAPID
Common or Proper name NOVORAPID FLEXTOUCH 100U 5X3ML NOVORAPID FLEXTOUCH 100U 5X3ML
Company Name NOVO NORDISK CANADA INC NOVO NORDISK CANADA INC
Ingredients INSULIN ASPART INSULIN ASPART
Strength(s) 100UNIT 100UNIT
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS
Packaging size EA EA
ATC code A10AB A10AB
ATC description INSULINS AND ANALOGUES INSULINS AND ANALOGUES
Reason for discontinuation Business reasons Other (Please describe in comments)
Anticipated discontinuation date 2023-07-31 2023-07-31
Actual discontinuation date
Remaining supply date 2023-07-31 2023-07-01
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Patients who continue to have coverage for NovoRapid® FlexTouch® have the option to transition to the Penfill® format with NovoPen® 4, our durable insulin device that is available free-of-charge for patients at the pharmacy. Patients who continue to have coverage for NovoRapid® FlexTouch® and Levemir® FlexTouch® formats have the option to transition to the Penfill® format with NovoPen® 4, our durable insulin device that is available free-of-charge for patients at the pharmacy.
Health Canada comments